Navigation Links
Senetek PLC Announces New Investor Communication Hotline
Date:4/1/2009

NAPA, Calif., April 1 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, today announced plans for the creation of a new communication hotline for the expressed purpose of keeping the investment community updated on key events. Bi-weekly updates will be recorded on a designated call-in number which is targeted to be up and running in early May. In addition, callers will be able to leave their contact information regarding any questions they may have.

The Company will periodically supplement the hotline with live investor teleconferences to announce and discuss significant material events. Frank J. Massino, Chairman and Chief Executive Officer stated, "that in today's volatile business and political environments, it is important to keep our shareholders updated in a timely manner on events shaping the Company."

About Senetek PLC:

Senetek PLC (OTCBB:SNKTY) is a Life Sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's websites: www.senetekplc.com www.pyratine-6.com www.pyratinexr.com

This news release contains statements that may be considered 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act. Forward-looking statements by their nature involve substantial uncertainty, and actual results may differ materially from those that might be suggested by such statements. Important factors identified by the Company that it believes could result in such material differences are described in the Company's Annual Report on Form 10-K for the year 2008. However, the Company necessarily can give no assurance that it has identified or will identify all of the factors that may result in any particular forward-looking statement materially differing from actual results, and the Company assumes no obligation to correct or update any forward-looking statements which may prove to be inaccurate, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Senetek PLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Senetek PLC Announces 2008 Annual General Meeting Voting Results
2. Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology
3. Senetek Affirms Strong Financial Position
4. Senetek PLC Reports Second Quarter 2008 Financial Results
5. Senetek PLC Reports First Quarter 2008 Financial Results
6. Senetek PLC Announces Appointments of Key Personnel
7. Senetek PLC in Dispute With Marketer of Pyratine-6(TM)
8. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
9. ACM Global Central Lab Announces Partnership with Chindexs United Family Hospitals in China
10. Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
11. ArunA Biomedical Announces Co-development of Fully Validated Induced Pluripotent Stem Cell Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Mass spectrometry is becoming more widely for clinical ... driven by its potential to perform challenging analyses in complex matrices and sample types. ... be addressed for it to be routinely used for medical testing. , ...
(Date:3/28/2017)... Summary This report provides all ... its partnering interests and activities since 2010. Description The ... insight into the partnering activity of one of the world,s ... are prepared upon purchase to ensure inclusion of the most ... report will be delivered in PDF format within 1 working ...
(Date:3/28/2017)... , March 28, 2017 Dr. ... international life sciences corporation Anpac Bio-Medical Science ... a new, international record, processing and reporting over ... "Cancer Differentiation Analysis" (CDA) liquid biopsy tests. ... Nobel Prize Laureate Summit publications, Anpac Bio,s CDA ...
(Date:3/28/2017)... ... March 28, 2017 , ... METTLER ... modules. These weigh modules are designed according to European Hygienic Engineering & ... As fully integrated weighing solutions, SWB805 MultiMount weigh modules reduce contamination risk ...
Breaking Biology Technology:
(Date:3/1/2017)...  Aware, Inc. (NASDAQ: AWRE), a leading supplier of ... Moberg has resigned, effective March 3, 2017, as ... and Treasurer of Aware citing a desire to retire.  ... of the Board of Directors of Aware. ... and co-President, General Counsel has been named Chief Executive ...
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
(Date:2/16/2017)... Feb. 16, 2017  Genos, a community for ... it has received Laboratory Accreditation from the College ... presented to laboratories that meet stringent requirements around ... rigorous processes. "Genos is committed to ... practices. We,re honored to be receiving CAP accreditation," ...
Breaking Biology News(10 mins):